首页> 美国卫生研究院文献>Laryngoscope Investigative Otolaryngology >Clinical efficacy of a topical lactic acid bacterial microbiome in chronic rhinosinusitis: A randomized controlled trial
【2h】

Clinical efficacy of a topical lactic acid bacterial microbiome in chronic rhinosinusitis: A randomized controlled trial

机译:局部乳酸菌微生物组在慢性鼻-鼻窦炎中的临床疗效:一项随机对照试验

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

ObjectiveA locally disturbed commensal microbiome might be an etiological factor in chronic rhinosinusitis (CRS) in general and in CRS without nasal polyps (CRSsNP) in particular. Lactic acid bacteria (LAB) have been suggested to restore commensal microbiomes. A honeybee LAB microbiome consisting of various lactobacilli and bifidobacteria have been found potent against CRS pathogens in vitro. Recently, we examined effects of single nasal administrations of this microbiome in healthy subjects and found it inert. In this study, we examined effects of repeated such administrations in patients with CRSsNP.
机译:总体而言,局部干扰的共生微生物组可能是慢性鼻-鼻窦炎(CRS)的病因,尤其是无鼻息肉的CRS(CRSsNP)的病因。乳酸菌(LAB)已被建议恢复共生微生物组。已发现由各种乳酸菌和双歧杆菌组成的蜜蜂LAB微生物组在体外对CRS病原体有效。最近,我们检查了该微生物组的单次鼻腔给药对健康受试者的影响,并发现它是惰性的。在这项研究中,我们检查了重复给药对CRSsNP患者的影响。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号